These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 20579254

  • 21. Patent on stem cell studies puts U.S. officials in bind.
    Stolberg SG.
    N Y Times Web; 2001 Aug 17; ():A1, A16. PubMed ID: 12155477
    [No Abstract] [Full Text] [Related]

  • 22. The current embryonic stem cell research federal funding policy. Undue respect to minority ethical considerations?
    Saltzberg J.
    J Leg Med; 2008 Aug 17; 29(4):505-21. PubMed ID: 19023778
    [No Abstract] [Full Text] [Related]

  • 23. Embryos, stem cells, morality and public policy: difficult connections.
    Momeyer RW.
    Cap Univ Law Rev; 2003 Aug 17; 31(1):93-104. PubMed ID: 15156894
    [No Abstract] [Full Text] [Related]

  • 24. Embryonic stem cells, Francis Collins, and the NIH.
    Lancet; 2009 Jul 18; 374(9685):175. PubMed ID: 19616701
    [No Abstract] [Full Text] [Related]

  • 25. Embryo stem cell research: ten years of controversy.
    Robertson JA.
    J Law Med Ethics; 2010 Jul 18; 38(2):191-203. PubMed ID: 20579242
    [Abstract] [Full Text] [Related]

  • 26. Private ethics boards and public debate.
    Tauer CA.
    Hastings Cent Rep; 1999 Jul 18; 29(2):43-5. PubMed ID: 10321344
    [No Abstract] [Full Text] [Related]

  • 27. Industry and academia in transition.
    Kennedy D.
    Science; 2003 Nov 21; 302(5649):1293. PubMed ID: 14631000
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ethical questions to ponder in the European stem cell patent debate.
    Curley D, Sharples A.
    J Biolaw Bus; 2006 Nov 21; 9(3):12-6. PubMed ID: 17152135
    [Abstract] [Full Text] [Related]

  • 30. Stem cells caught in morality clause.
    Siva N.
    Nat Biotechnol; 2009 Feb 21; 27(2):109. PubMed ID: 19204675
    [No Abstract] [Full Text] [Related]

  • 31. The use of stem cells in biomedical research. Biotechnology Industry Organization (BIO) position statement.
    Biotechnology Industry Organization.
    J Biolaw Bus; 1999 Feb 21; 3(1):40-4. PubMed ID: 11933970
    [Abstract] [Full Text] [Related]

  • 32. Science and the law. Working through the patent problem.
    Walsh JP, Cohen WM, Arora A.
    Science; 2003 Feb 14; 299(5609):1021. PubMed ID: 12586928
    [No Abstract] [Full Text] [Related]

  • 33. [Federal judge and government of the United States against gene patenting].
    Cassier M, Stoppa-Lyonnet D.
    Med Sci (Paris); 2012 Feb 14; 28 Spec No 2():11-5. PubMed ID: 22759889
    [No Abstract] [Full Text] [Related]

  • 34. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB, DeVille KA.
    Am J Bioeth; 2002 Feb 14; 2(3):29-39. PubMed ID: 12230852
    [No Abstract] [Full Text] [Related]

  • 35. Stem cell patents--reexamination/litigation--the last 5 years.
    Shyntum Y, Kalkreuter E.
    Tissue Eng Part B Rev; 2009 Mar 14; 15(1):87-90. PubMed ID: 19260807
    [Abstract] [Full Text] [Related]

  • 36. The attack of the clones: patent law and stem cell research.
    Rimmer M.
    J Law Med; 2003 May 14; 10(4):488-505. PubMed ID: 12852321
    [Abstract] [Full Text] [Related]

  • 37. Stem cell research in Canada: business opportunities for U.S. companies.
    Reicin C, McMahon E.
    J Biolaw Bus; 2005 May 14; 8(1):61-4. PubMed ID: 16538805
    [Abstract] [Full Text] [Related]

  • 38. Patenting of human embryonic stem cells in Europe.
    Treichel P.
    Biotechnol J; 2009 Apr 14; 4(4):462-4. PubMed ID: 19370720
    [No Abstract] [Full Text] [Related]

  • 39. Teetering on the brink.
    Nat Biotechnol; 2010 Oct 14; 28(10):987. PubMed ID: 20944563
    [Abstract] [Full Text] [Related]

  • 40. Stem cells: The cell division.
    Abbott A.
    Nature; 2011 Dec 15; 480(7377):310-2. PubMed ID: 22170661
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.